SenseTime Sweeps Four Championships at MICCAI 2018, Showcasing China's Original AI Innovation in Healthcare

VCBeat (WeChat Official Account: vcbeat) has learned that SenseTime and its joint laboratory recently swept four major competitions at MICCAI 2018, the premier international conference on medical image computing. The competitions included “Left Ventricle Quantification,” “Left Atrium Segmentation,” “Stroke Lesion Segmentation,” and “Intervertebral Disc Segmentation and Localization.” Projects led by young team members garnered recognition, showcasing China’s original innovation in AI healthcare on the global stage in Spain. These competitions attracted participation from top academic institutions and renowned medical technology organizations worldwide, including Fudan University, the Massachusetts Institute of Technology (MIT), Harvard Medical School, the University of Oxford, and King’s College London.

Group Photo of the Winners of the MICCAI AtriaSeg Left Atrial Segmentation Challenge; SenseTime Team Wins Championship

MICCAI (Medical Image Computing and Computer Assisted Intervention) is an internationally recognized premier academic conference, holding the highest prestige and influence in the fields of medical image computing and computer-assisted intervention.

In the four competitions won by SenseTime, the focus was on addressing critical challenges in cardiology, neurology, and orthopedics. The research directions closely align with common clinical difficulties encountered in hospitals, including heart disease, stroke differentiation, diagnosis, and research, as well as studies on lower back pain and lumbar disc degeneration. AI technology directly targets the “core issues” in clinical practice, providing effective technical support for clinical “diagnosis, treatment, and recovery.”

A representative from SenseTime Smart Healthcare stated that this competition provided an excellent opportunity for young researchers to hone their skills. The four major awards not only demonstrated the team’s research prowess in the field of AI-driven healthcare but also laid a solid foundation of technical support and original innovation for the future deployment of application scenarios. “We aim to truly empower the healthcare industry with AI technology by addressing pain points based on actual clinical needs. While academic achievements and technological breakthroughs form the basis, our primary focus is on integrating them into real-world clinical workflows to enhance physicians’ efficiency and precision. In the long run, such ‘high efficiency’—encompassing both productivity and outcomes—will facilitate the gradual flow of medical resources from urban centers to grassroots levels, benefiting more patients and healthcare providers.”

Previously, SenseTime released its first medical product prototype—the SenseCare Intelligent Diagnosis and Treatment Platform—marking its initial disclosure of a strategic layout in smart healthcare. The company aims to address clinical needs by leveraging AI to empower the entire “diagnosis-treatment-recovery” workflow. Building on its extensive technical expertise in multi-industry and multi-scenario AI applications, SenseTime has consolidated China’s original AI capabilities to deepen its exploration of the healthcare sector. By overcoming technical bottlenecks and leveraging proprietary technologies as competitive advantages, the company conducts comprehensive investigations into various clinical scenarios and their associated pain points and challenges. This approach maximizes the value of AI technology and effectively addresses practical challenges faced by physicians in their daily work.

SenseTime is a globally leading artificial intelligence platform company and has been recognized as the “world’s most valuable AI innovation enterprise.” Built on two decades of accumulated expertise in AI research and development, and guided by its mission to “uphold original innovation and let AI drive human progress,” SenseTime has established a world-class, independently developed deep learning supercomputing center—the largest AI R&D base in Asia. Its innovative achievements in fields such as facial recognition, image recognition, text recognition, medical imaging analysis, video analytics, and autonomous driving have empowered AI-driven transformation across more than ten vertical industries.

In addition to leading the industry in technological prowess, SenseTime also ranks first in market share across multiple vertical sectors in terms of commercial revenue. To date, SenseTime has established collaborations with more than 700 renowned universities, enterprises, and institutions both in China and abroad, including the Massachusetts Institute of Technology (MIT), The Chinese University of Hong Kong, Qualcomm, NVIDIA, Honda, Alibaba, Suning, China Mobile, UnionPay, Wanda Group, HNA Group, Huawei, Xiaomi, OPPO, vivo, Weibo, iFlytek, and the Cyberspace Administration of China. These partnerships span numerous industries such as smart cities, smartphones, interactive entertainment and advertising, automotive, finance, and retail, jointly driving technological upgrades through AI across various sectors and leading the tide of development in the AI era.

In May 2018, SenseTime announced the completion of its $620 million C+ funding round, bringing its total fundraising to over $1.6 billion and its valuation to more than $4.5 billion. This solidified its position as the AI unicorn with the largest total funding and highest valuation globally. SenseTime has established branches in Hong Kong, Beijing, Shenzhen, Shanghai, Chengdu, Hangzhou, Kyoto and Tokyo (Japan), and Singapore, gathering top talent from around the world to jointly build a world-class company pioneering original artificial intelligence technologies. Intelligent manufacturing in China, benefiting the globe.